经皮门静脉溶栓及血管内支架置入术治疗移植后门静脉导管血栓形成
Percutaneous portal vein thrombolysis and endovascular stent for management of posttransplant portal venous conduit thrombosis.
作者信息
Bhattacharjya T, Olliff S P, Bhattacharjya S, Mirza D F, McMaster P
机构信息
Department of Radiodiagnosis, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom.
出版信息
Transplantation. 2000 May 27;69(10):2195-8. doi: 10.1097/00007890-200005270-00042.
BACKGROUND
Thrombosis of a portal vein conduit after liver transplant is an uncommon clinical situation. Percutaneous thrombolytic therapy for this condition has not been widely described.
METHODS
We describe a case of thrombosis of a portal vein (PV) conduit subsequent to orthotopic liver transplantation that was successfully treated by percutaneous portal vein thrombolysis by using tissue plasminogen activator, angioplasty, and endovascular stent placement.
RESULTS
A satisfactory outcome was achieved with a patent portal vein, on ultrasound, at 8-month follow-up.
CONCLUSION
A percutaneous transhepatic approach to treatment of thrombosis of a portal vein conduit appears to be a promising technique to use to avoid surgery, with good medium-term results.
背景
肝移植后门静脉导管血栓形成是一种罕见的临床情况。针对这种情况的经皮溶栓治疗尚未得到广泛描述。
方法
我们描述了一例原位肝移植后门静脉（PV）导管血栓形成的病例，该病例通过使用组织纤溶酶原激活剂、血管成形术和血管内支架置入术进行经皮门静脉溶栓成功治疗。
结果
在8个月的随访中，超声检查显示门静脉通畅，取得了满意的结果。
结论
经皮经肝途径治疗门静脉导管血栓形成似乎是一种有前景的技术，可避免手术，中期效果良好。
Zotero 插件